A Double-blind Randomized Trial on Comparison of Intravenous and Intramuscular Oxytocin for Preventing Atonic Primary Post Partum Haemorrhage in Third Stage of Labour

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201902721929705

Enrollment

232

Registered

2019-02-12

Start date

2019-02-19

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

intravenous oxytocin group

Intramuscular oxytocin group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Healthy pregnant women Age of 18 years or older Term singleton pregnancy Normotensive pregnancy Spontaneous onset of labour Vaginal delivery Informed consent.

Exclusion criteria

Exclusion criteria: Preterm gestation; Grandmultiparity; Those with previous Caesarean section or uterine surgery; Those with any other contraindication to vaginal delivery; Multiple pregnancy, Suspected fetal macrosomia Polyhydramnios; Previous history of post partum haemorrhage; Those on induction of labour; Those with medical illness like hypertention, diabetics, hepatic disease, renal disease, pre eclampsia, and coagulation disorders Antepartum haemorrhage Uterine fibroids in pregnancy.

Design outcomes

Primary

Measure	Time frame
Mean postpartum blood loss.Maternal hypotension	—

Secondary

Measure	Time frame
Need for additional uterotonics, need for blood transfusion, need for surgical intervention, postpartum maternal anaemia, maternal shivering, maternal nausea and vomiting	—

Countries

Nigeria

Contacts

Public ContactChukwuemeka EZEAMA

CONSULTANT

emeka.ezeama@gmail.com+2348037167284

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026